FORM SC 13D

Company

abrdn Life Sciences Investors

Filed

December 29, 2023

Accession Number

0001062993-23-023268

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →